Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Unlike the investment banks, we created StockStory to provide independent analysis that helps you determine which companies are truly worth following. Keeping that in mind, here is one stock where Wall Street’s positive outlook is supported by strong fundamentals and two where consensus estimates seem disconnected from reality.
Two Stocks to Sell:
Somnigroup (SGI)
Consensus Price Target: $93.44 (44.4% implied return)
Established through the merger of Tempur-Pedic and Sealy in 2012, Somnigroup (NYSE: SGI) is a bedding manufacturer known for its innovative memory foam mattresses and sleep products
Why Are We Bearish on SGI?
- Annual revenue growth of 11.6% over the last five years was below our standards for the consumer discretionary sector
- Free cash flow margin is on track to jump by 1.5 percentage points next year, meaning the company will have more resources to pursue growth initiatives, repurchase shares, or pay dividends
- Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions
At $64.71 per share, Somnigroup trades at 18.1x forward P/E. Read our free research report to see why you should think twice about including SGI in your portfolio.
STERIS (STE)
Consensus Price Target: $263.13 (26.5% implied return)
With a mission critical role in preventing healthcare-associated infections, STERIS (NYSE: STE) provides infection prevention products, sterilization services, and medical equipment that help healthcare facilities and life science companies maintain sterile environments.
Why Does STE Fall Short?
- Sales trends were unexciting over the last two years as its 7.4% annual growth was below the typical healthcare company
- Static adjusted operating margin over the last five years shows it couldn’t become more efficient
- ROIC of 5.7% reflects management’s challenges in identifying attractive investment opportunities
STERIS’s stock price of $207.99 implies a valuation ratio of 18.3x forward P/E. To fully understand why you should be careful with STE, check out our full research report (it’s free).
One Stock to Watch:
Jabil (JBL)
Consensus Price Target: $429.56 (44.5% implied return)
With manufacturing facilities spanning the globe from China to Mexico to the United States, Jabil (NYSE: JBL) provides electronics design, manufacturing, and supply chain solutions to companies across various industries, from healthcare to automotive to cloud computing.
Why Could JBL Be a Winner?
- Massive revenue base of $33.59 billion makes it a well-known name that influences purchasing decisions
- Share repurchases have amplified shareholder returns as its annual earnings per share growth of 18.4% exceeded its revenue gains over the last five years
- ROIC punches in at 34.7%, illustrating management’s expertise in identifying profitable investments, and its returns are climbing as it finds even more attractive growth opportunities
Jabil is trading at $297.22 per share, or 18.8x forward P/E. Is now the right time to buy? See for yourself in our comprehensive research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.
